Leukemia and Lymphoma

This resource provides further information on subtypes of blood cancers and their specific markers.

DURAInnovations powered reagents were created to optimize your workflow.

Laboratories and healthcare professionals now have access to an FDA-validated test that provides consistent results to aid in the diagnoses of these serious cancers. This represents a major step forward for the hematology-oncology community.

Experts on L&L Immunophenotyping answer your questions and share their experience with ClearLLab Solutions.

Explore guidelines and ready-to-use solutions that help to optimize your L&L workflows.

View examples from ClearLLab casebooks and download your copy.

Several organizations launched a pilot program in Uganda and Kenya with the goal of using flow cytometry to improve diagnosis of blood cancers.